NCT02013284Suspended
Is Our Microbiome a Predictor of Cardiac Risk
Is Our Microbiome a Predictor of Cardiac Risk?
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Reason given: Reorganizing study personnel and funding
Brief summary (registry, in English)
The purpose of this study is to determine a relationship between a person's flora/bacteria in their gut (the intestinal microbiome) and their risk of cardiovascular disease. Investigators will look at inflammatory markers in the blood and also look at the genome of the bacteria in the gut.
- Status (registry)
- Suspended
- Study type
- Observational
- Enrollment
- 700 (estimated)
- First submitted
- 11 Dec 2013
- Start date
- Nov 2013
- Primary completion date
- Dec 2027
- Lead sponsor
- Mayo Clinic
- Diseases
- Coronary artery disease
- NCT number
- NCT02013284
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients currently on long-term antibiotics who cannot stop them for at least 2 weeks prior to providing a stool sample.
- Patients on chronic laxatives who cannot stop for at least 2 weeks prior to stool collection.
- Patients on probiotics and cannot stop for 2 weeks prior to giving a stool sample (yogurt is ok).
Other
- Patients who are unable to provide a stool sample to Mayo Clinic within 24 hours of collection utilizing Fed Ex overnight mail (i.e. people overseas who are unable to provide a sample before leaving the USA.)
Who the study is looking for
- Anyone undergoing cardiac catheterization for suspected coronary artery disease over age 18.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.